Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer

Expert Review of Molecular Diagnostics

Volumn 11, Issue 8, 2011, Pages 763-766

  Cho, William C S ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

early diagnosis; lung cancer; miRNA; molecular diagnostics; predictive marker; prognosis

Indexed keywords

MICRORNA; TUMOR MARKER;

ANGIOGENESIS; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SUSCEPTIBILITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; EDITORIAL; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; METASTASIS; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MICRORNAS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 80054963880     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.11.71     Document Type: Editorial

References (20)

1. Jemal A, Bray F, Center MM, Felay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61(2), 69-90 (2011).
2. Cho WC. MicroRNAs as therapeutic targets for lung cancer. Expert Opin. Ther. Targets 14(10), 1005-1008 (2010).
3. Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 42(8), 1273-1281 (2010).
4. Cho WC. Molecular diagnostics for monitoring and predicting therapeutic effect in cancer. Expert Rev. Mol. Diagn. 11(1), 9-12 (2011).
5. Cho WC. Recent progress in genetic variants associated with cancer and their implications in diagnostics development. Expert Rev. Mol. Diagn. 10(6), 699-703 (2010).
6. Chu H, Wang M, Shi D et al. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One 6(3), e18108 (2011).
7. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. MiR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J. Thorac. Oncol. 6(3), 482-488 (2011).
8. Chen X, Hu Z, Wang W et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int. J. Cancer DOI: 10.1002/ijc.26177 (2011) (Epub ahead of print).
9. Keller A, Leidinger P, Gislefoss R et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol. 8(3), 506-516 (2011).
10. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating microRNA expression profiles in early stage non-small cell lung cancer. Int. J. Cancer DOI:10.1002/ijc.26153 (2011) (Epub ahead of print).
11. Roth C, Kasimir-Bauer S, Pantel K, Schwarzenbach H. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol. Oncol. 5(3), 281-291 (2011).
12. Bianchi F, Nicassio F, Marzi M et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol. Med. 3(8), 495-503 (2011).
13. Boeri M, Verri C, Conte D et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl Acad. Sci. USA 108(9), 3713-3718 (2011).
14. Hu Z, Chen X, Zhao Y et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28(10), 1721-1726 (2010).
15. Watanabe K, Emoto N, Hamano E et al. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Int. J. Cancer DOI: 10.1002/ijc.26254 (2011) (Epub ahead of print).
16. Arora S, Ranade AR, Tran NL et al. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int. J. Cancer 129(11), 2621-2631 (2011).
17. Saito M, Schetter AJ, Mollerup S et al. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin. Cancer Res. 17(7), 1875-1882 (2011).
18. Donnem T, Lonvik K, Eklo K et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer 117(14), 3193-3200 (2011).
19. Cho WC, Chow AS, Au JS. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 8(1), 125-131 (2011).
20. Cho WC. MicroRNAs in cancer - from research to therapy. Biochim. Biophys. Acta 1805(2), 209-217 (2010).